MELAIU, OMBRETTA
 Distribuzione geografica
Continente #
NA - Nord America 2.573
EU - Europa 970
AS - Asia 939
SA - Sud America 180
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.689
Nazione #
US - Stati Uniti d'America 2.530
IT - Italia 461
SG - Singapore 347
CN - Cina 273
BR - Brasile 167
HK - Hong Kong 129
DE - Germania 110
SE - Svezia 104
VN - Vietnam 67
BG - Bulgaria 58
GB - Regno Unito 58
RU - Federazione Russa 39
FI - Finlandia 38
CA - Canada 33
TR - Turchia 32
FR - Francia 26
KR - Corea 20
UA - Ucraina 18
IN - India 16
BE - Belgio 14
EE - Estonia 10
CI - Costa d'Avorio 9
IQ - Iraq 9
AR - Argentina 8
PL - Polonia 8
BD - Bangladesh 7
CH - Svizzera 6
OM - Oman 6
UZ - Uzbekistan 6
JP - Giappone 5
MX - Messico 5
AT - Austria 4
NL - Olanda 4
DO - Repubblica Dominicana 3
ID - Indonesia 3
LT - Lituania 3
MA - Marocco 3
PK - Pakistan 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
EG - Egitto 2
ES - Italia 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
NG - Nigeria 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
AL - Albania 1
AM - Armenia 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
IE - Irlanda 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
ML - Mali 1
PE - Perù 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VE - Venezuela 1
Totale 4.689
Città #
Ashburn 286
Fairfield 248
Woodbridge 245
Serra 238
Dallas 208
Ann Arbor 175
Houston 172
Singapore 157
Chandler 146
Hong Kong 129
Santa Clara 128
Seattle 125
Cambridge 106
Shanghai 68
Beijing 62
Wilmington 61
Sofia 58
New York 46
Boardman 42
San Jose 42
Princeton 37
Florence 30
Pisa 29
Ottawa 27
Des Moines 25
Frankfurt am Main 25
Lawrence 25
Milan 25
Medford 23
Munich 22
Los Angeles 21
Boulder 16
Dong Ket 16
Istanbul 15
London 15
Brussels 14
Lancaster 14
Izmir 12
São Paulo 12
Dearborn 11
Daejeon 10
Helsinki 10
Lappeenranta 10
Seoul 10
Abidjan 9
Buffalo 9
Guangzhou 9
Hefei 9
Ho Chi Minh City 9
Jacksonville 9
Nanjing 9
Redondo Beach 9
Rome 9
Genoa 8
Phoenix 8
Redwood City 8
San Diego 8
Shenzhen 8
Hebei 7
Nanchang 7
The Dalles 7
Turku 7
Brooklyn 6
Council Bluffs 6
Pune 6
Bern 5
Bremen 5
Chicago 5
Columbus 5
Falls Church 5
Lucca 5
Porto Alegre 5
San Giuliano Terme 5
Shenyang 5
Tashkent 5
Warsaw 5
Baghdad 4
Brasília 4
Chengdu 4
Fortaleza 4
Hanoi 4
Messina 4
Muscat 4
Nuremberg 4
Rio de Janeiro 4
Tokyo 4
Vienna 4
Auburn Hills 3
Belo Horizonte 3
Contagem 3
Dakar 3
Empoli 3
Falkenstein 3
Fuzhou 3
Nürnberg 3
Quanzhou 3
Querétaro 3
Rio Grande 3
Wroclaw 3
Ankara 2
Totale 3.500
Nome #
Expression status of candidate genes in mesothelioma tissues and cell lines 323
A Novel Panel of Serum Biomarkers for MPM Diagnosis 283
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma 282
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 257
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 234
Risk of Differentiated Thyroid Carcinoma and Polymorphisms within the Susceptibility Cancer Region 8q24 232
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals 220
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma 213
Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated Immunoevasion. 212
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism 209
PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma 209
MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma. 196
A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma 189
Characterization of novel 3'untranslated regions and related polymorphisms of the gene NPPC, encoding for the C-type natriuretic peptide 189
The genetic susceptibility in the development of malignant pleural mesothelioma 186
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma 164
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors 147
Role of genetic variations on MHC class I antigen-processing genes in human cancer and viral-mediated diseases 136
Nuovi bio-marcatori per la sorveglianza clinica di lavoratori ex-esposti 130
Counter-regulation of regulatory T cells by autoreactive CD8 + T cells in rheumatoid arthritis 130
A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: Comparison of four immunometric assays 124
ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP 122
Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors 111
Identification of overexpressed genes in malignant pleural mesothelioma 108
The regulatory roles of phosphatases in cancer 106
Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma 89
Totale 4.801
Categoria #
all - tutte 12.756
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.756


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021184 0 0 0 0 0 0 5 16 52 17 32 62
2021/2022294 1 18 14 24 51 32 6 24 13 7 15 89
2022/2023440 37 60 43 41 39 51 3 48 76 0 40 2
2023/2024249 26 18 52 9 27 52 13 9 6 5 8 24
2024/20251.013 0 34 5 79 132 130 88 48 123 122 105 147
2025/2026768 115 163 159 79 124 88 40 0 0 0 0 0
Totale 4.801